Won Jong Kim
Overview
Explore the profile of Won Jong Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
2734
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Cho H, Kim J, Lim J, Kang Y, Kim W
J Control Release
. 2025 Feb;
381:113576.
PMID: 40010409
Overcoming the physical barrier of the extracellular matrix (ECM) surrounding tumors is a critical challenge in achieving effective immune checkpoint blockade (ICB). The dense ECM impedes the infiltration of immune...
2.
Lee S, Kang S, Kim W
ACS Nano
. 2025 Feb;
19(8):7742-7754.
PMID: 39982901
Targeted protein degradation (TPD) strategies offer a significant advantage over traditional small molecule inhibitors by selectively degrading disease-causing proteins. While small molecules can lead to recurrence and resistance due to...
3.
Park M, Lim J, Lee S, Nah Y, Kang Y, Kim W
Adv Mater
. 2025 Jan;
37(7):e2417735.
PMID: 39745112
Immunotherapy, particularly immune checkpoint blockade (ICB) therapies, has revolutionized oncology. However, it encounters challenges such as inadequate drug accumulation and limited efficacy against "cold" tumors characterized by lack of T...
4.
Choi D, Boo Y, Park S, Xu L, Kim S, Yi S, et al.
Adv Healthc Mater
. 2024 Dec;
:e2402005.
PMID: 39641188
High-entropy alloy (HEA) nanoparticles possess finely tunable and multifunctional catalytic activity due to their extremely diverse adsorption sites. Their unique properties enable HEA nanoparticles to mimic the complex interactions of...
5.
Kim H, Saravanakumar G, Lee S, Jang S, Kang S, Park M, et al.
Biomaterials
. 2024 Nov;
315:122966.
PMID: 39578179
No abstract available.
6.
Lee J, Kang Y, Lee H, Saravanakumar G, Park S, Ahn S, et al.
Biomaterials
. 2024 Nov;
315:122904.
PMID: 39490061
Despite the success of immune checkpoint blockade (ICB) therapy in various cancers, its efficacy faces challenges in glioblastoma (GBM) due to the immunosuppressive cold-tumor microenvironment. The scarcity of tumor-infiltrating T...
7.
Kim H, Saravanakumar G, Lee S, Jang S, Kang S, Park M, et al.
Biomaterials
. 2024 Oct;
314:122896.
PMID: 39426123
Non-viral vectors for mRNA delivery primarily include lipid nanoparticles (LNPs) and polymers. While LNPs are known for their high mRNA delivery efficiency, they can induce excessive immune responses and cause...
8.
Nah Y, Kim J, Lee S, Koh W, Kim W
J Control Release
. 2024 Aug;
374:525-537.
PMID: 39173954
Inflammation-related diseases are often marked by elevated levels of nitric oxide (NO) and reactive oxygen species (ROS), which play important roles in the modulation of inflammation. However, the development of...
9.
3D Multiparametric Photoacoustic Computed Tomography of Primary and Metastatic Tumors in Living Mice
Kim J, Lee J, Choi S, Lee H, Yang J, Jeon H, et al.
ACS Nano
. 2024 Jun;
18(28):18176-18190.
PMID: 38941553
Photoacoustic computed tomography (PACT), an emerging imaging modality in preclinical cancer research, can provide multiparametric 3D information about structures, physiological functions, and pharmacokinetics. Here, we demonstrate the use of high-definition...
10.
Vadevoo S, Kang Y, Gunassekaran G, Lee S, Park M, Jo D, et al.
Theranostics
. 2024 Apr;
14(6):2605-2621.
PMID: 38646639
Nab-paclitaxel (Abx) is widely employed in malignant tumor therapy. In tumor cells and pro-tumoral M2-type macrophages, the IL4 receptor (IL4R) is upregulated. This study aimed to elucidate the selective delivery...